# BridgeBio Pharma, Inc.: Form 8-K, filed Jun 24, 2020

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2020-06-24
- Accepted by EDGAR: Jun 24, 2020, 17:14 ET
- Period: 2020-06-23
- Accession: 0001193125-20-177774
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312520177774/d948258d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312520177774/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312520177774/d948258d8k.htm

Filed Jun 24, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-177774. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
